Title: Michael Neu - Innovator in Pharmaceutical Formulations
Introduction
Michael Neu is an inventor based in Edingen-Neckarhausen, Germany. He has worked with notable companies such as AbbVie Biotechnology Ltd and Transmit Gesellschaft für Technologietransfer mbH. Although he currently holds no granted patents, his contributions to the field of pharmaceutical formulations are noteworthy.
Latest Patent Applications
Michael Neu's latest patent applications include "High Concentration Anti-TNFalpha Antibody Liquid Formulations." This invention provides a liquid aqueous pharmaceutical formulation comprising a human anti-TNFa antibody, or an antigen-binding portion thereof, which reduces pain associated with injection in a subject by at least about 50% when compared to injecting an otherwise identical formulation comprising at least one salt and/or at least one buffer. The formulation also aims to enhance bioavailability upon subcutaneous administration into a subject. It may include a therapeutic protein, such as a human anti-TNF-alpha antibody, or an antigen-binding portion thereof, or a biosimilar thereof.
Conclusion
Michael Neu's work in developing innovative pharmaceutical formulations demonstrates his commitment to improving patient care through science and technology. His ongoing efforts in this field may lead to significant advancements in the treatment of various conditions.